Heart-Valve Win May Prod Johnson & Johnson, Abbott Laboratories to Shop for Technology
Bloomberg -- Abbott Laboratories and Johnson & Johnson, pursuing a potential $2 billion market for heart valves that don’t require rib-cracking surgery, are shopping for companies with the new technology.